ENDRA Life Sciences

NDRANasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$5.707 M

$4.60 +0.55%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$7.03M

Loss-making

Shares outstanding

1,240,751

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus — ranked by market cap

All 28 →

#23IridexIRIX$14.5M
#24Nexalin TechnologyNXL$7.77M
#25ENDRA Life SciencesNDRA$5.71M
#26iTonicITOC$4.91M
#27NuwellisNUWE$4.81M

Where these numbers come from

Share counts and financials for ENDRA Life Sciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.